← Back

Katalyze AI

Mountain View, United States

seed$10.5M raisedFreshly fundedhealthtechdeeptechAI

Total Raised

$10.5M

Stage

seed

Location

Mountain View, United States

Founded

2022

Team size

51-200

Links

About Katalyze AI

San Francisco-based life sciences AI startup building an agentic operating system for pharmaceutical manufacturing and life sciences.

What sets it apart

Its agentic operating system combines a source-grounded ontology layer with expert-designed AI agents trained on decades of knowledge from over a hundred tenured lab and floor experts to deliver audit-defensible AI in regulated manufacturing environments.

Sectors

healthtechdeeptechAIlife sciences AISaaSenterprise AI

Business

ModelSaaS

Customerpharmaceutical companies and biopharma manufacturers

Notable

  • Raised $10.5M in seed funding announced in July 2026
  • Adopted by 5 of the 20 largest global pharmaceutical companies
  • Appointed Hannes Bretschneider as Chief AI Officer in December 2025

Backing funds on Raise

Funding rounds

seed$10.5M

17 Jul 2026

Led by Bonfire Ventures

With Inovia Capital, Ripple Ventures, Alumni Ventures, Gokul Rajaram, Farzad Soleimani

Source ↗

Explore the market

FAQ

What does Katalyze AI do?

San Francisco-based life sciences AI startup building an agentic operating system for pharmaceutical manufacturing and life sciences.

Where is Katalyze AI based?

Katalyze AI is based in Mountain View, United States, founded in 2022.

How much has Katalyze AI raised?

Katalyze AI has raised $10.5M in tracked funding and is currently at the seed stage.

Who has invested in Katalyze AI?

Investors in Katalyze AI include Bonfire Ventures, Inovia Capital, Ripple Ventures, Alumni Ventures, Gokul Rajaram and Farzad Soleimani.